Advanced search - COVID-19 Research Repository - COVID-19 - Infectious diseases - Health protection - Our areas of work - Public Health Scotland

Filter by publication date

From

Month Year

Test

To

Month Year

Test

Apply date filter

Showing 8 results

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

Author

Alexander, James L.; Kennedy, Nicholas A.; Ibraheim, Hajir; Anandabaskaran, Sulak; Saifuddin, Aamir; Castro Seoane, Rocio; Liu, Zhigang; Nice, Rachel; Bewshea, Claire; D'Mello, Andrea and 21 others

Source

The Lancet Gastroenterology & Hepatology

Type

Journal article

Published

01 April 2022
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Author

Lin, Simeng; Kennedy, Nicholas A.; Saifuddin, Aamir; Sandoval, Diana Muñoz; Reynolds, Catherine J.; Seoane, Rocio Castro; Kottoor, Sherine H.; Pieper, Franziska P.; Lin, Kai Min; Butler, David K. and 23 others

Source

Nature Communications

Type

Journal article

Published

16 March 2022
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Author

Kennedy, Nicholas A.; Lin, Simeng; Goodhand, James R; Chanchlani, Neil; Hamilton, Benjamin; Bewshea, Claire; Nice, Rachel; Chee, Desmond; Cummings, J R Fraser; Fraser, Aileen and 16 others

Source

Gut

Type

Journal article

Published

26 April 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Author

Kennedy, Nicholas A.; Goodhand, James R; Bewshea, Claire; Nice, Rachel; Chee, Desmond; Lin, Simeng; Chanchlani, Neil; Butterworth, Jeffrey; Cooney, Rachel; Croft, Nicholas M and 21 others

Source

Gut

Type

Journal article

Published

19 March 2021
COVID-19 and IBD drugs: should we change anything at the moment?

Author

Lees, Charlie W; Irving, Peter M; Beaugerie, Laurent

Source

Gut

Type

Journal article

Published

19 November 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel

Author

Din, Shahida; Kent, Alexandra J.; Pollok, Richard; Meade, Susanna; Kennedy, Nicholas A.; Arnott, Ian; Beattie, R. Mark; Chua, Felix; Cooney, Rachel; Dart, Robin J and 24 others

Source

Gut

Type

Journal article

Published

07 September 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

Author

Kennedy, Nicholas A.; Hansen, Richard; Younge, Lisa; Mawdsley, Joel; Beattie, R. Mark; Din, Shahida; Lamb, Christopher A.; Smith, Philip J; Selinger, Christian; Limdi, Jimmy K. and 14 others

Source

Frontline Gastroenterology

Type

Journal article

Published

16 June 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Author

Kennedy, Nicholas A.; Jones, Gareth Rhys; Lamb, Christopher A.; Appleby, Richard; Arnott, Ian; Beattie, R. Mark; Bloom, Stuart; Brooks, Alenka J; Cooney, Rachel; Dart, Robin J and 26 others

Source

Gut

Type

Journal article

Published

01 June 2020

There are no more search results.